PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.\', \'Wuhan YZY Biopharma Co., Ltd, Wuhan, 430075, China.\', \'Shanghai Serum Bio-technology Co., Ltd, Shanghai, 201701, China.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China; University of the Chinese Academy of Sciences, Beijing, 100039, China.\', \'University of the Chinese Academy of Sciences, Beijing, 100039, China; CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.\', \'CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China.\', \'Shanghai Serum Bio-technology Co., Ltd, Shanghai, 201701, China. Electronic address: chenze2005@hotmail.com.\', \'State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, 430071, China; University of the Chinese Academy of Sciences, Beijing, 100039, China. Electronic address: xiaogf@wh.iov.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0166-3542(20)30282-510.1016/j.antiviral.2020.104868
?:doi
?:hasPublicationType
?:journal
  • Antiviral research
is ?:pmid of
?:pmid
?:pmid
  • 32659292
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.925
?:rankingScore_hIndex
  • 105
is ?:relation_isRelatedTo_publication of
?:title
  • Immunoglobulin fragment F(ab\')2 against RBD potently neutralizes SARS-CoV-2 in vitro.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32659292>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32659292>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all